[Treatment of immune thrombocytopenia: a retrospective study of 40 patients]

Clicks: 342
ID: 270656
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #5 of 11 articles by views in la revue de medecine interne

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
ITP is a rare disorder occurring most frequently in middle aged patients. Because of high relapse or no response rates, many treatments should be used. Dapsone offers a good efficacy without major side effects. RTX is well tolerated and allows a good response rate. The use of new agents like thrombo …
Reference Key
s2010la[treatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Audia S;Lakomy D;Guy J;Leguy-Seguin V;Berthier S;Aho S;Lorcerie B;Bonnotte B;;
Journal la revue de medecine interne
Year 2010
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.